Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,450 total articles

Duos Technologies Joins Russell 2000® Index

Duos Technologies Joins Russell 2000® Index

Duos Technologies Group, Inc., a provider of modular edge data centers and technology infrastructure, has been added to the Russell 2000 Index following the 2026 Russell indexes annual reconstitution. This inclusion reflects Duos's growth trajectory and expanding capabilities in modular data centers and GPU-as-a-Service solutions targeting AI infra…

Trex Tees Up Major Visibility on Golf’s Biggest Stages

Trex Tees Up Major Visibility on Golf’s Biggest Stages

Trex Company, Inc., a leading wood-alternative decking brand traded on the NYSE as TREX, is increasing its brand exposure through sponsorships of the American Century Championship and Golf Channel's Big Break x Good Good presented by Golf Galaxy. These initiatives aim to engage consumers across sports, entertainment, and digital platforms, highligh…

KLIM AND RESEARCH FRONTIERS ENTER INTO LICENSING AGREEMENT

KLIM AND RESEARCH FRONTIERS ENTER INTO LICENSING AGREEMENT

Research Frontiers Incorporated has entered into a licensing and product development agreement with Klim to integrate its SPD-SmartGlass light control technology into motorcycle helmets, goggles, visors, and related rider products. This collaboration aims to enhance rider comfort and safety by dynamically managing light, glare, and heat under varyi…

SPS Commerce Announces Agreement to Sell 3P Revenue Recovery Business

SPS Commerce Announces Agreement to Sell 3P Revenue Recovery Business

SPS Commerce announced the sale of its 3P Revenue Recovery business, originally acquired through its acquisition of Carbon6 Technologies in 2025. The company retains the 1P revenue recovery segment which supports major retailers including Amazon and Walmart. The sale generated $9.5 million in cash but will result in an estimated $20 million loss in…

Critical Metals Corp Nasdaq-CRML Has Successfully Acquired a Strategic Arctic Ship Housing Asset Providing Long Term & Turn-Key Accommodations at Site for Up to 300 Workers at Tanbreez

Critical Metals Corp Nasdaq-CRML Has Successfully Acquired a Strategic Arctic Ship Housing Asset Providing Long Term & Turn-Key Accommodations at Site for Up to 300 Workers at Tanbreez

Critical Metals Corp has acquired the Ocean Endeavour, an ice-strengthened vessel capable of housing 180 personnel, to support its Tanbreez critical minerals project in Greenland. This acquisition aims to improve logistical efficiency, workforce safety, and operational capabilities in the remote Arctic environment while minimizing the impact on loc…

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

Moleculin Reports Positive Phase 2/3 MIRACLE Interim Results, With Annamycin Complete Remission Rates 3-fold Greater than Control

Moleculin Biotech reported positive interim results from the Phase 2/3 MIRACLE trial evaluating Annamycin combined with cytarabine in patients with relapsed or refractory acute myeloid leukemia (AML). Both Annamycin dose arms showed significantly higher complete remission rates compared to control after a single treatment cycle. These results sugge…

Quantum X Labs Appoints Leading Physics Engineering Expert to Advance its Quantum and Fault-Tolerant Quantum Computing Technologies

Quantum X Labs Appoints Leading Physics Engineering Expert to Advance its Quantum and Fault-Tolerant Quantum Computing Technologies

Quantum X Labs Ltd. announced the appointment of Dr. Ira Wolfson to its leadership team to advance its quantum and fault-tolerant computing technologies. Dr. Wolfson's extensive experience in physics and engineering is expected to accelerate development of quantum computing architectures, algorithms, and sensing technologies aiming for commercializ…

Flash Sports & Media Holdings, Inc. (NASDAQ: FLZH) Announces Non-Binding Letter of Intent to Potentially Acquire Controlling Interest in Approximately $35 Million-Revenue Hospitality Group in an All-Preferred Stock Transaction

Flash Sports & Media Holdings, Inc. (NASDAQ: FLZH) Announces Non-Binding Letter of Intent to Potentially Acquire Controlling Interest in Approximately $35 Million-Revenue Hospitality Group in an All-Preferred Stock Transaction

Flash Sports & Media Holdings, Inc. announced a non-binding letter of intent to acquire a 51% controlling interest in Nooa Holdings Ltd, a Dubai hospitality company generating approximately $35 million in annual revenue. The $51 million purchase price will be paid entirely in newly created Series A Preferred Stock, requiring no cash outlay or immed…

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Candel Therapeutics Announces Initiation of Global Pivotal Phase 3 AURORA Trial Evaluating Aglatimagene Besadenovec (CAN-2409) in Advanced Non-Small Cell Lung Cancer Patients with Inadequate Response to Immune Checkpoint Inhibitors

Candel Therapeutics announced the start of their global pivotal phase 3 AURORA trial evaluating aglatimagene besadenovec (CAN-2409) combined with valacyclovir and pembrolizumab versus standard docetaxel chemotherapy in patients with metastatic non-squamous NSCLC progressing despite prior immune checkpoint inhibitor therapy. The trial aims to enroll…

Adeia Enters into Multi-Year IP License Agreement with RPX

Adeia Enters into Multi-Year IP License Agreement with RPX

Adeia Inc. announced a multi-year intellectual property license agreement with RPX Corporation, granting 10 RPX member companies access to Adeia's extensive media technology portfolio. This deal supports advancements in AI-driven e-commerce experiences such as intelligent search, personalization, and virtual shopping. RPX's syndicated approach stre…

POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM

POET Technologies Recaps Highlights of CEO’s Update on Commercial Activities and Provides Results of 2026 AGM

POET Technologies provided an update on its ongoing production ramp-up targeting volume shipments starting in the second half of 2026 and expansion to meet demand of up to 1 million units per month by the end of 2027. The company raised substantial capital to support growth, has multiple active customer engagements exceeding $100 million in potenti…

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Vamorolone Demonstrates On-Target Glucocorticoid Activity Without the Immunosuppression Characteristic of Traditional Corticosteroids at Clinical Doses

Catalyst Pharmaceuticals reported positive topline results from a Phase 1 clinical study showing that vamorolone provides balanced glucocorticoid activity with effective cortisol suppression but without significant immunosuppressive effects at clinical doses, supporting its potential use to treat a range of chronic inflammatory rare diseases. The s…

Upexi Partners with Blueprint to Stake Solana Treasury Assets

Upexi Partners with Blueprint to Stake Solana Treasury Assets

Upexi, Inc., a NASDAQ-listed digital asset treasury company focused on Solana, has partnered with Blueprint, an institutional-grade staking and digital-asset infrastructure provider, to stake a portion of its Solana holdings. This strategic partnership aims to leverage Blueprint's high-performance validator infrastructure to enhance yield and suppo…

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

Genelux Announces Publication of Translational Analysis Supporting Immune Activation and Chemotherapy Sensitization with Olvi‑Vec in Ovarian Cancer

Genelux Corporation announced publication of translational analyses from its Phase 1b/2 VIRO-15 trial showing that Olvi-Vec, an oncolytic immunotherapy, modulates the tumor microenvironment and restores platinum chemotherapy sensitivity in platinum-resistant/refractory ovarian cancer. These findings provide mechanistic support for clinical benefits…

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM)

Cogent Biosciences has submitted a New Drug Application (NDA) to the FDA for bezuclastinib to treat Advanced Systemic Mastocytosis (AdvSM), based on positive data from the pivotal APEX trial demonstrating a 65% objective response rate and a favorable safety profile. This submission marks the company's third NDA for bezuclastinib in six months, with…